Germany: Euro databank "would aid surveillance"
This article was originally published in Clinica
Executive Summary
In the ten years since it came into force, Germany's medical products law (MPG) - on the cusp of its third amendment - has established itself as a useful market surveillance tool. Increased market transparency and improved patient and user protection are two of the law's main benefits. So said Becton Dickinson (Germany) device safety co-ordinator Wilhelm Emmerich.